Results 321 to 330 of about 174,356 (352)
Some of the next articles are maybe not open access.

Inhibition of BRAF and MEK in BRAF-mutant melanoma

The Lancet, 2015
Keiran S M, Smalley, Vernon K, Sondak
openaire   +2 more sources

Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial

Nature Medicine, 2023
Marios Giannakis   +2 more
exaly  

BRAF-V600E

2013
Stephan Mose   +56 more
openaire   +1 more source

Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond

Nature Reviews Cancer, 2014
Matthew Holderfield   +2 more
exaly  

BRAF Inhibitors

2013
Stephan Mose   +56 more
openaire   +1 more source

Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma

Nature Medicine, 2019
Paolo A Ascierto   +2 more
exaly  

Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma

Nature Medicine, 2019
Antoni Ribas   +2 more
exaly  

BRAF

2011
openaire   +1 more source

Atezolizumab plus cobimetinib and vemurafenib in BRAF-mutated melanoma patients

Nature Medicine, 2019
Ryan J Sullivan   +2 more
exaly  

Home - About - Disclaimer - Privacy